Urogen Pharma (URGN)

Urogen Pharma (URGN) Financial Statements


Urogen Pharma Financial Overview

Urogen Pharma's market cap is currently ―. The company's EPS TTM is $-3.723; its P/E ratio is -4.02; Urogen Pharma is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.87. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 20.85M$ 21.14M$ 17.19M$ 18.09M$ 16.10M
Gross Profit$ 18.48M$ 18.70M$ 14.93M$ 15.83M$ 14.08M
EBIT$ -18.07M$ -20.32M$ -26.64M$ -25.36M$ -22.43M
EBITDA$ -17.39M-$ -26.15M$ -8.62M$ -21.99M
Net Income Common Stockholders$ -17.31M$ -24.14M$ 47.63M$ -28.87M$ -25.83M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 147.42M$ 48.12M$ 65.87M$ 100.78M$ 95.91M
Total Assets$ 193.63M$ 95.36M$ 111.85M$ 135.62M$ 128.47M
Total Debt$ 99.54M$ 99.50M$ 99.34M$ 99.12M$ 73.73M
Net Debt$ -47.88M$ 51.39M$ 33.48M$ -1.65M$ -22.18M
Total Liabilities$ 235.63M$ 233.79M$ 229.51M$ 224.98M$ 191.76M
Stockholders Equity$ -41.99M$ -138.43M$ -116.55M$ -89.36M$ -63.29M
Cash Flow-
Free Cash Flow$ -17.40M-$ -25.58M$ -21.77M$ -17.77M
Operating Cash Flow$ -17.30M-$ -25.55M$ -21.75M$ -17.61M
Investing Cash Flow$ 401.00K-$ 6.27M$ 23.11M$ -35.49M
Financing Cash Flow$ 116.08M-$ 671.00K$ 25.37M$ 1.10M
Currency in USD

Urogen Pharma Earnings and Revenue History

Urogen Pharma Debt to Assets

Urogen Pharma Cash Flow

Urogen Pharma Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis